Health

STAT+: Doctors Without Borders urges Roche to cut price of drug now recommended for Covid-19


STAT+: Doctors Without Borders urges Roche to cut price of drug now recommended for Covid-19

After the World Health Organization recommended a Roche (RHHBY) drug to treat severe Covid-19, Doctors Without Borders quickly urged the drug maker to “end its monopoly” by lowering the price of the medicine and sharing its technology in order to quickly widen access.

Meta-analyses of more than 10,000 patients who were enrolled in 27 clinical trials founds that two medicines — Roche’s Actemra and Kevzara from Sanofi — lowered the risk of death by 13% compared to standard care, especially when given with corticosteroids. The WHO noted these were the first drugs to be found effective against Covid-19 since corticosteroids were recommended last September.

Continue to STAT+ to read the full story…


Source link

Check Also
Close
Back to top button